Machine Learning in Drug Metabolism Study

被引:3
作者
Sinha, Krishnendu [1 ]
Ghosh, Jyotirmoy [2 ]
Sil, Parames Chandra [3 ,4 ]
机构
[1] Jhargram Raj Coll, Dept Zool, Jhargram 721507, India
[2] Banwarilal Bhalotia Coll, Dept Chem, Asansol 713303, India
[3] Bose Inst, Dept Div Mol Med, Kolkata 700054, India
[4] Bose Inst, Div Mol Med, Kolkata 700054, India
关键词
Machine learning; algorithms; deep learning; drug metabolism; metabolites; molecular docking; PHASE-I; PREDICTION; FUTURE; MECHANISMS; DISCOVERY; TOXICITY; NETWORK; MODELS; WEB;
D O I
10.2174/1389200224666221227094144
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metabolic reactions in the body transform the administered drug into metabolites. These metabolites exhibit diverse biological activities. Drug metabolism is the major underlying cause of drug overdose-related toxicity, adversative drug effects and the drug's reduced efficacy. Though metabolic reactions deactivate a drug, drug metabolites are often considered pivotal agents for off-target effects or toxicity. On the other side, in combination drug therapy, one drug may influence another drug's metabolism and clearance and is thus considered one of the primary causes of drug-drug interactions. Today with the advancement of machine learning, the metabolic fate of a drug candidate can be comprehensively studied throughout the drug development procedure. Naive Bayes, Logistic Regression, k-Nearest Neighbours, Decision Trees, different Boosting and Ensemble methods, Support Vector Machines and Artificial Neural Network boosted Deep Learning are some machine learning algorithms which are being extensively used in such studies. Such tools are covering several attributes of drug metabolism, with an emphasis on the prediction of drug-drug interactions, drug-target-interactions, clinical drug responses, metabolite predictions, sites of metabolism, etc. These reports are crucial for evaluating metabolic stability and predicting prospective drug-drug interactions, and can help pharmaceutical companies accelerate the drug development process in a less resource-demanding manner than what in vitro studies offer. It could also help medical practitioners to use combinatorial drug therapy in a more resourceful manner. Also, with the help of the enormous growth of deep learning, traditional fields of computational drug development like molecular interaction fields, molecular docking, quantitative structure-to-activity relationship (QSAR) studies and quantum mechanical simulations are producing results which were unimaginable couple of years back. This review provides a glimpse of a few contextually relevant machine learning algorithms and then focuses on their outcomes in different studies.
引用
收藏
页码:1012 / 1026
页数:15
相关论文
共 50 条
  • [31] Machine learning, the kidney, and genotype-phenotype analysis
    Sealfon, Rachel S. G.
    Mariani, Laura H.
    Kretzler, Matthias
    Troyanskaya, Olga G.
    KIDNEY INTERNATIONAL, 2020, 97 (06) : 1141 - 1149
  • [32] Machine Learning in Drug Discovery: A Review
    Dara, Suresh
    Dhamercherla, Swetha
    Jadav, Surender Singh
    Babu, C. H. Madhu
    Ahsan, Mohamed Jawed
    ARTIFICIAL INTELLIGENCE REVIEW, 2022, 55 (03) : 1947 - 1999
  • [33] Machine Learning Applications in Drug Repurposing
    Yang, Fan
    Zhang, Qi
    Ji, Xiaokang
    Zhang, Yanchun
    Li, Wentao
    Peng, Shaoliang
    Xue, Fuzhong
    INTERDISCIPLINARY SCIENCES-COMPUTATIONAL LIFE SCIENCES, 2022, 14 (01) : 15 - 21
  • [34] Machine learning in preclinical drug discovery
    Catacutan, Denise B.
    Alexander, Jeremie
    Arnold, Autumn
    Stokes, Jonathan M.
    NATURE CHEMICAL BIOLOGY, 2024, 20 (08) : 960 - 973
  • [35] Machine Learning Applications in Drug Repurposing
    Fan Yang
    Qi Zhang
    Xiaokang Ji
    Yanchun Zhang
    Wentao Li
    Shaoliang Peng
    Fuzhong Xue
    Interdisciplinary Sciences: Computational Life Sciences, 2022, 14 : 15 - 21
  • [36] Machine Learning Techniques and Drug Design
    Gertrudes, J. C.
    Maltarollo, V. G.
    Silva, R. A.
    Oliveira, P. R.
    Honorio, K. M.
    da Silva, A. B. F.
    CURRENT MEDICINAL CHEMISTRY, 2012, 19 (25) : 4289 - 4297
  • [37] A novel paradigm on data and knowledge-driven drug formulation development: Opportunities and challenges of machine learning
    Wang, Xinrui
    Liu, Zhenda
    Lin, Xiao
    Hong, Yanlong
    Shen, Lan
    Zhao, Lijie
    JOURNAL OF INDUSTRIAL INFORMATION INTEGRATION, 2025, 44
  • [38] Comparative Study of Deep Learning and Machine Learning Techniques for Corrosion and Cracks Detection in Nuclear Power Plants
    Allah, Malik Al-Abed
    Shams, Afaque
    Toor, Ihsan Ul Haq
    Iqbal, Naveed
    CHALLENGES AND RECENT ADVANCEMENTS IN NUCLEAR ENERGY SYSTEMS, SCOPE 2023, 2024, : 279 - 287
  • [39] Machine learning and deep learning approaches for enhanced prediction of hERG blockade: a comprehensive QSAR modeling study
    Liu, Jie
    Khan, Md Kamrul Hasan
    Guo, Wenjing
    Dong, Fan
    Ge, Weigong
    Zhang, Chaoyang
    Gong, Ping
    Patterson, Tucker A.
    Hong, Huixiao
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2024, 20 (07) : 665 - 684
  • [40] Efficient machine learning model for predicting drug-target interactions with case study for Covid-19
    El-Behery, Heba
    Attia, Abdel-Fattah
    El-Feshawy, Nawal
    Torkey, Hanaa
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2021, 93